Mucus Hypersecretion
Mucus Hypersecretion - Related Videos
05:10
Three-dimensional Quantification of Intestinal Mucus Using Whole-mount Tissue Imaging
0 Views •
2025
This study presents a 3D imaging method using whole-mount intestinal tissues and multi-photon microscopy to quantify secreted mucus, enabling precise volumetric analysis and visualization of mucus dynamics in response to stimuli like carbamoylcholine chloride.
08:47
Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer
0 Views •
Cited by 5 •
2022
The viscoelastic properties of mucus play a critical role in mucociliary clearance. However, traditional mucus rheological techniques require complex and time-consuming approaches. This study provides a detailed protocol for the use of a benchtop rheometer that can rapidly and reliably perform viscoelastic measurements.
09:13
Macro-Rheology Characterization of Gill Raker Mucus in the Silver Carp, Hypophthalmichthys molitrix
0 Views •
Cited by 1 •
2020
This protocol presents a method to perform rheology characterization of mucus that resides on gill rakers (GRs) of the silver carp. Viscoelastic characteristics of GR-mucus, obtained by measuring viscosity, storage and loss moduli, are evaluated for the apparent yield stress to understand the filter feeding mechanism in GRs.
06:57
The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
0 Views •
Cited by 11 •
2017
The mucus plugged airways of cystic fibrosis (CF) patients are an ideal environment for microbial pathogens to thrive. The manuscript describes a novel method for studying the CF lung microbiome in an environment that mimics where they cause disease and how alterations of chemical conditions can drive microbial dynamics.
02:44
In Vitro Gut Model to Assess Bacterial Adhesion and Internalization
0 Views •
2026
Source: Calatayud Arroyo, M., et al. Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface. J. Vis. Exp. (2018).This video demonstrates an in vitro gut host–microbe model to study bacterial viability. A co-culture of Caco-2 and HT29-MTX cells is incubated with bacteria pre-treated under simulated digestive conditions. Epithelial barrier integrity is assessed using transepithelial electrical resistance, and fractions from the medium, solubilized...
FAQs
Chronic airway inflammation can stimulate both goblet cells and submucosal glands, causing them to release more mucin than under normal conditions. Goblet cells contribute mucus within the epithelial lining, while submucosal glands add secretions from deeper tissue. Their combined activity increases the amount of material that must be moved through the airways.
Mucociliary clearance depends on moving airway secretions away from the epithelial surface. When mucus becomes thickened, this removal process can be impaired, allowing secretions to persist and accumulate. The resulting buildup may obstruct airflow, linking altered mucus properties to respiratory effects such as persistent cough and breathlessness.
Mucus normally supports airway defense by trapping particles on epithelial surfaces. Excessive production changes that benefit when the added material becomes difficult to clear or contributes to obstruction. This shift illustrates how the same biological system can protect tissue at an appropriate level yet disrupt airflow and normal function when inflammation drives overproduction.
Investigation can connect several outcomes: stimulation of mucus-producing cells, increased mucin release, thickened secretions, impaired mucociliary clearance, and restricted airflow. Researchers can also relate these changes to symptoms including persistent cough and breathlessness. Considering the chain from cellular activity to airway function helps explain how inflammation produces clinically relevant respiratory effects.
Mucus hypersecretion research contributes to the study of asthma, chronic obstructive pulmonary disease, and respiratory infection. These conditions provide contexts for examining how inflammation, increased secretion, and impaired clearance affect the airways. Comparing them helps clarify why excessive mucus is relevant across multiple forms of respiratory dysfunction rather than belonging to a single disease.
The process provides a framework for investigating therapies with two complementary goals: reducing mucus production and improving its clearance. These approaches address different points in the problem, either limiting excessive mucin release or helping remove accumulated secretions. Their relevance lies in restoring more effective airway function and reducing the effects associated with obstructed airflow.